Case 2 — A useful source-review update: what changed since the opening post?
The final index entry can say documented, unresolved or corrected, with a date and links to the relevant posts. This template is not an actual customer endorsement.
Case 3 — Redacting a review: which details should stay private?
Remove names, addresses, prescription identifiers, contact details, account references, tracking tokens and scannable codes from the public copy. Keep originals privately rather than destroying the only evidence.
Case 3 — Redacting a review: which details should stay private?
Use opaque redactions in a flattened exported copy, then reopen that copy and inspect it at full size. Do not rely on a translucent marker or a reversible edit layer.
Case 3 — Redacting a review: which details should stay private?
Image metadata can also contain sensitive information. Check the exported file with a suitable metadata viewer and share only the copy you have inspected.
Case 3 — Redacting a review: which details should stay private?
Batch and product information may be relevant to a pharmacist or regulator. Decide what belongs in that private enquiry rather than automatically publishing every field or redacting the professional’s only useful evidence.
Case 3 — Redacting a review: which details should stay private?
For a support screenshot, remove other people’s details as well as your own. Summarise irrelevant portions instead of uploading an entire conversation.
Case 3 — Redacting a review: which details should stay private?
The public post should still state the question, the sequence of events and the evidence that can be described safely. Privacy protection need not turn it into an unsupported accusation.
Case 4 — A source review checklist that separates evidence from reassurance
How can a review template make evidence gaps visible without asserting that a seller is safe?
Exercise PHARMACY-00818/4: address this question within its stated limits.
Case 4 — A source review checklist that separates evidence from reassurance
Record dates, jurisdiction, product identification and what can actually be verified. Delivery or professional-looking packaging alone cannot establish medicine identity, quality or suitability.
Case 4 — A source review checklist that separates evidence from reassurance
Clarification for “A source review checklist that separates evidence from reassurance”: the point beginning “Record dates, jurisdiction, product identification and what…” belongs to the question as written. It should not be read as a report that a new check, purchase or experiment has been completed. Review focus: scope. Keep the stated question separate from any broader claim.
Case 4 — A source review checklist that separates evidence from reassurance
Method note for “A source review checklist that separates evidence from reassurance”: use “Record dates, jurisdiction, product identification and what…” as a row heading in a proposed working record. Put the statement, its supporting source or measurement, and any unresolved detail in separate fields. This proposes a format; it supplies no additional evidence. Keep the stated question separate from any broader claim.
Case 4 — A source review checklist that separates evidence from reassurance
Limit of the answer in “A source review checklist that separates evidence from reassurance”: “Record dates, jurisdiction, product identification and what…” is an excerpt from the discussion, not an independent verification. A reader needs the relevant original material before treating an interpretation as established. Review focus: scope. Keep the stated question separate from any broader claim.
Case 4 — A source review checklist that separates evidence from reassurance
Correction note for “A source review checklist that separates evidence from reassurance”: retain the wording beginning “Record dates, jurisdiction, product identification and what…” in the record. If later material changes it, add the date, the changed wording and the source for that change; do not invent a completed correction here. Keep the stated question separate from any broader claim.
Case 4 — A source review checklist that separates evidence from reassurance
Summary draft for “A source review checklist that separates evidence from reassurance”: the answer addresses “Record dates, jurisdiction, product identification and what…”; the related point is “Delivery or professional-looking packaging alone cannot establish medicine…”. Keep both connected to the opening question, and mark any conclusion needing further records as unresolved. Review focus: scope. Keep the stated question separate from any broader claim.
Case 5 — Storage question: start with the supplied label
A general storage question omits the product label and the conditions it was exposed to. What information should be taken to a pharmacist?
Exercise PHARMACY-00818/5: address this question within its stated limits.